CRADLE-5 is the first pragmatic stepped-wedge trial of a Vital Signs Alert device in a low-income country, evaluating its effectiveness and scale-up across eight districts in Sierra Leone, where maternal mortality rates remain one of the highest globally. The study involved over 93,000 deliveries, trained 2,100+ health workers, and assessed outcome variations across districts and facilities.